|
|
Line 50: |
Line 50: |
| | | |
| <div class="row" > | | <div class="row" > |
− | <div class="6u 12u(narrower) wow bounceInLeft"> | + | <div class="6u 12u(narrower) wow bounceInLeft" style="visibility:hidden;"> |
| <h4 class="header4 wow fadeInDown delay05"><span>Increasing the levels of NADH</span> <i class="faabig flaticon-speedometer26"></i></h4> | | <h4 class="header4 wow fadeInDown delay05"><span>Increasing the levels of NADH</span> <i class="faabig flaticon-speedometer26"></i></h4> |
| | | |
Line 61: |
Line 61: |
| </div> | | </div> |
| | | |
− | <div class="6u 12u(narrower) wow bounceInRight"> | + | <div class="6u 12u(narrower) wow bounceInRight" style="visibility:hidden;"> |
| <h4 class="header4 wow fadeInDown delay05"> <span>PncB is not toxic if overexpressed in <span style="font-style:italic">E.coli</span></span> <i class="faabig flaticon-shield114"></i></h4> | | <h4 class="header4 wow fadeInDown delay05"> <span>PncB is not toxic if overexpressed in <span style="font-style:italic">E.coli</span></span> <i class="faabig flaticon-shield114"></i></h4> |
| <p style="clear:both;"> | | <p style="clear:both;"> |
Line 78: |
Line 78: |
| <div class="row"> | | <div class="row"> |
| <div class="12u 12u(narrower)"> | | <div class="12u 12u(narrower)"> |
− | <h4 class="header4 wow fadeInDown delay05"> <span>PncB enhances NAD production by ~2.5 fold</span><i class="faabig flaticon-bars-graphic"></i></h4> | + | <h4 class="header4 wow fadeInDown delay05" style="visibility:hidden;"> <span>PncB enhances NAD production by ~2.5 fold</span><i class="faabig flaticon-bars-graphic"></i></h4> |
| </div> | | </div> |
| </div> | | </div> |
Line 87: |
Line 87: |
| | | |
| <div class="row"> | | <div class="row"> |
− | <div class="7u 12u(narrower) wow bounceInLeft centered"> | + | <div class="7u 12u(narrower) wow bounceInLeft centered" style="visibility:hidden;"> |
| <p style="text-align:center;"> | | <p style="text-align:center;"> |
| <a class="fancybox" rel="group" href="https://static.igem.org/mediawiki/2015/4/45/Unitn_pics_pncb_StarndarRatioPncB.png" ><img src="https://static.igem.org/mediawiki/2015/5/5e/Unitn_pics_pncb_StarndarRatioPncB_thumb.png" alt="" style="width:100%; max-width:700px;"/></a> | | <a class="fancybox" rel="group" href="https://static.igem.org/mediawiki/2015/4/45/Unitn_pics_pncb_StarndarRatioPncB.png" ><img src="https://static.igem.org/mediawiki/2015/5/5e/Unitn_pics_pncb_StarndarRatioPncB_thumb.png" alt="" style="width:100%; max-width:700px;"/></a> |
Line 93: |
Line 93: |
| </div> | | </div> |
| | | |
− | <div class="5u 12u(narrower) wow bounceInRight"> | + | <div class="5u 12u(narrower) wow bounceInRight" style="visibility:hidden;"> |
| <p class="image_caption" style="clear:both;"><span>__Title of the Figure__</span> NAD and NADH levels were quantified with Sigma NAD /NADH quantification kit (MAK037) following the instructions described in the technical bulletin. Panel A: Standard curve (0, 20, 40, 60, 80, 100 pmole/well of NADH)). Panel B: NAD/NADH levels for three biological samples of BBa_K1604030 (green) and one negative control BBa_K731201 (blue). The cells were grown as described previously.</p> | | <p class="image_caption" style="clear:both;"><span>__Title of the Figure__</span> NAD and NADH levels were quantified with Sigma NAD /NADH quantification kit (MAK037) following the instructions described in the technical bulletin. Panel A: Standard curve (0, 20, 40, 60, 80, 100 pmole/well of NADH)). Panel B: NAD/NADH levels for three biological samples of BBa_K1604030 (green) and one negative control BBa_K731201 (blue). The cells were grown as described previously.</p> |
| </div> | | </div> |
Line 100: |
Line 100: |
| | | |
| <div class="row"> | | <div class="row"> |
− | <div class="7u 12u(narrower) wow bounceInLeft"> | + | <div class="7u 12u(narrower) wow bounceInLeft" style="visibility:hidden;"> |
| <p style="clear:both" class="image_caption"><span>__Title of the Figure__</span> Lane B samples 2-7 calibration curve (0, 20, 40, 60, 80, 100 pmole/well of NADH). Lane C samples 2-9 NAD total levels; Lane D samples 2-9 NAD total repeated with a 2 fold concentrated sample; Lane E NADH only; Lane F NADH only, repeated with a 2 fold concentrated sample. In lanes C-F the order of the samples is: 2 technical replicates of the negative control, and 2 technical replicates of each of the 3 biological samples of BBa_K1604031. The plate was read with a Tecan Infinite M-200 pro instrument at 450 nm. The measurements were taken after 0.5, 1, 2, 3, 4 hours to allow color development. The data shown are representative of the best measurement at 2 hours.</p> | | <p style="clear:both" class="image_caption"><span>__Title of the Figure__</span> Lane B samples 2-7 calibration curve (0, 20, 40, 60, 80, 100 pmole/well of NADH). Lane C samples 2-9 NAD total levels; Lane D samples 2-9 NAD total repeated with a 2 fold concentrated sample; Lane E NADH only; Lane F NADH only, repeated with a 2 fold concentrated sample. In lanes C-F the order of the samples is: 2 technical replicates of the negative control, and 2 technical replicates of each of the 3 biological samples of BBa_K1604031. The plate was read with a Tecan Infinite M-200 pro instrument at 450 nm. The measurements were taken after 0.5, 1, 2, 3, 4 hours to allow color development. The data shown are representative of the best measurement at 2 hours.</p> |
| </div> | | </div> |
| | | |
− | <div class="5u 12u(narrower) wow bounceInRight centered"> | + | <div class="5u 12u(narrower) wow bounceInRight centered" style="visibility:hidden;"> |
| <p> | | <p> |
| <a class="fancybox" rel="group" href="https://static.igem.org/mediawiki/2015/2/26/Unitn_pics_pncb_wells.jpg" title=""><img src="https://static.igem.org/mediawiki/2015/1/1b/Unitn_pics_pncb_wells_thumb.jpg" alt="" style="width:100%; max-width:500px;"/></a> | | <a class="fancybox" rel="group" href="https://static.igem.org/mediawiki/2015/2/26/Unitn_pics_pncb_wells.jpg" title=""><img src="https://static.igem.org/mediawiki/2015/1/1b/Unitn_pics_pncb_wells_thumb.jpg" alt="" style="width:100%; max-width:500px;"/></a> |